
Our contribution to the open source research project to develop a practical and economically viable synthesis of Praziquantel, a drug for the treatment of schistosomiasis, caught national and international attention. In response to this an interview with our senior scientist Jean Paul Seerden was published in the Dutch magazines Medicines volume 3, issue 6, December 2011 and C2W 20, 26 November 2011. Please note that both articles are in Dutch.
Groningen/Buffalo Grove – May 15 2012 Syncom BV and Austin Chemical Inc. today announce that Aust…
Syncom PhD student Maarten van de Meijden will give an oral presentation of part of his research con…